Literature DB >> 8710386

Testing NF-kappa B1-p50 antibody specificity using knockout mice.

D S Pereira1, D B Kushner, R P Ricciardi, F L Graham.   

Abstract

Cell extracts from knockout mice can provide definitive proof of antibody specificity. Two NF-kappa B1-p50 antibodies, sc-114 (a commercial antibody) and NR1157, were observed to recognize proteins having distinct electrophoretic mobilities of 52-55 kD and 50 kD, respectively, by Western blot analysis. In order to discriminate the specificity of these antibodies for NF-kappa B1-p50, whole cell extracts derived from NF-kappa B1-p105 knockout mice were employed. While the NR1157 antibody completely failed to recognize its 50 kD product in p105-/- knockout extracts, the sc-114 antibody still strongly recognized its 52-55 kD product. These data demonstrate that NR1157, but not sc-114, is highly specific for NF-kappa B1-p50 by Western blot analysis. In addition, these results highlight the utility of knockout cell extracts for discerning antibody specificity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710386

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.

Authors:  Jiping Zhang; Mary Ann Warren; Suzanne F Shoemaker; Margot M Ip
Journal:  Endocrinology       Date:  2006-09-28       Impact factor: 4.736

2.  Reduced phosphorylation of p50 is responsible for diminished NF-kappaB binding to the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells.

Authors:  D B Kushner; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  Minimal NF-κB activity in neurons.

Authors:  Samuel J Listwak; Priyanka Rathore; Miles Herkenham
Journal:  Neuroscience       Date:  2013-07-17       Impact factor: 3.590

4.  Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies.

Authors:  Miles Herkenham; Priyanka Rathore; Pierre Brown; Samuel J Listwak
Journal:  J Neuroinflammation       Date:  2011-10-14       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.